perflutren has been researched along with Liver Dysfunction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sawhney, S; Wilson, SR | 1 |
| Bhayana, D; Burns, PN; Jang, HJ; Kim, TK; Wilson, SR | 1 |
| Barr, RG; Chammas, MC; Chaubal, NG; Chen, MH; Choi, BI; Claudon, M; Clevert, DA; Correas, JM; Cosgrove, DO; Dietrich, CF; Ding, H; Forsberg, F; Fowlkes, JB; Gibson, RN; Goldberg, BB; Kudo, M; Lassau, N; Leen, EL; Mattrey, RF; Moriyasu, F; Nolsøe, CP; Piscaglia, F; Solbiati, L; Weskott, HP; Wilson, SR; Xu, HX | 1 |
| Carpenter, AP; Rosenberg, ML | 1 |
1 trial(s) available for perflutren and Liver Dysfunction
| Article | Year |
|---|---|
Contrast material-enhanced abdominal US examinations with DMP 115 (DEFINITY) provides additional diagnostic information with potential for changes in patient management.
Topics: Contrast Media; Fluorocarbons; Humans; Image Enhancement; Kidney Diseases; Liver Diseases; Patient Care; Ultrasonography | 2002 |
3 other study(ies) available for perflutren and Liver Dysfunction
| Article | Year |
|---|---|
Can Ultrasound With Contrast Enhancement Replace Nonenhanced Computed Tomography Scans in Patients With Contraindication to Computed Tomography Contrast Agents?
Topics: Aged; Contraindications, Drug; Contrast Media; Female; Fluorocarbons; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2017 |
Hypervascular liver masses on contrast-enhanced ultrasound: the importance of washout.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Female; Fluorocarbons; Humans; Liver Diseases; Male; Middle Aged; Neovascularization, Pathologic; Retrospective Studies; Ultrasonography | 2010 |
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.
Topics: Anaphylaxis; Biopsy, Needle; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Contraindications; Contrast Media; Diagnosis, Differential; Drug Hypersensitivity; Drug Interactions; Ferric Compounds; Fluorocarbons; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Iron; Liver; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Liver Transplantation; Oxides; Phospholipids; Risk Factors; Sulfur Hexafluoride; Ultrasonography, Doppler; Ultrasonography, Interventional | 2013 |